Stock Track | BAO PHARMA-B Soars 20.48% Intraday on MSCI Inclusion, Chairman's Share Purchase Plan, and Buyback Proposal

Stock Track05-18

BAO PHARMA-B's stock soared 20.48% during intraday trading on Monday, driven by multiple positive developments.

The surge follows the company's announcement of its inclusion in the MSCI Global Small Cap Index, effective after the market close on May 29, 2026. This inclusion is expected to enhance the company's global visibility and attract passive fund inflows.

Additionally, the company disclosed that Chairman Dr. Liu Yanjun plans to increase his shareholding in the company, expressing confidence in its prospects. BAO PHARMA-B also intends to propose a share buyback mandate at its upcoming Annual General Meeting, authorizing the repurchase of up to 10% of its issued H shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment